top of page

Houston Oncology Summit: MD Anderson's Katy Rezvani, an expert in NK cell therapies, gives an overview of what is in development in this space

blonca9
Sep 26, 2024
1 min read

She describes the properties that she believes give NK cells an edge over T-cells, and discussed work in cell therapies, engagers, and more.

Brought to you by:

ree

Recent Posts

William Blair Senior Biotech Analyst Andy Hsieh reacts to today's oral obesity data from Viking's VK2735 and recent data from Lilly's orforglipron

William Blair Senior Biotech Analyst Andy Hsieh reacts to today's oral obesity data from Viking's VK2735 and recent data from Lilly's orforglipron

AI News: While most AI in healthcare is aimed at helping physicians better diagnose and treat disease, CureWise is built for patients to help understand their conditions and ask the right questions

AI News: While most AI in healthcare is aimed at helping physicians better diagnose and treat disease, CureWise is built for patients to help understand their conditions and ask the right questions

As independent tenant advocates, Savills can help biotech and pharma companies make their real estate footprint align with their objectives and be more efficient

As independent tenant advocates, Savills can help biotech and pharma companies make their real estate footprint align with their objectives and be more efficient

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.

Learn more about Genezen

bottom of page